Join AlphaMaven

The Home Of Alternative Investments

Register For Free Learn More Create Investment Listing

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Alternative Investment Posts

RGM M&A Event:  Zendesk (ZEN) Acquired By PE Consortium Led By Hellman & Friedman And Permira For $77.50/Share
Hedge Fund RGM Value Opportunity Fund, LP Views: 1

It was announced on Friday that Zendesk (ZEN) is being acquired by a private equity consortium led by Hellman & Friedman and Permira for $77.50/share in cash, representing a 34% premium to the closing price on Thursday, June 23rd. ZEN represents approximately 3.5% of Fund capital.

We started a position in ZEN in Q4 2021 following the announcement of their proposed acquisition of Momentive (MNTV) for $4 billion in an all-stock deal. We felt at that time that ZEN’s stock price overreacted


Member Posts:

Most popular| Most recent
Quantitative Global Macro Program - AlphaMaven Performance Report
Managed Futures Quantitative Global Macro Fund, LP #Investment Update
Golden Eagle Growth Fund - AlphaMaven Performance Report
Hedge Fund Golden Eagle Hypergrowth Strategy #Investment Update
AlphaMaven Crypto Traders Index
Crypto AlphaMaven Crypto Traders Index #Investment Update
AlphaMaven Cannabis Index
Cannabis AlphaMaven Cannabis Index #Investment Update
Cooper Creek Partners (Class A) - AlphaMaven Performance Report
Hedge Fund Cooper Creek Partners LLC (Class A) #Investment Update
Mulvaney Global Markets Fund - AlphaMaven Performance Report
Managed Futures The Mulvaney Global Markets Fund, Ltd. #Investment Update
Andrea Alms Video:  Money In Motion 164 - MBA Job Market
Private Equity BrookDell Partners #Video
Psalion Liquid Yield Accounts - AlphaMaven Performance Report
Crypto Psalion Liquid Yield Accounts #Investment Update
Psalion Liquid Yield Accounts Posts Its May 2025 Returns
Crypto Psalion Liquid Yield Accounts #Investment Update
O'Brien Investment Group's Quantitative Global Macro Fund, LP Posts Its June 2025 Results
Managed Futures Quantitative Global Macro Fund, LP #Investment Update
Golden Eagle Hypergrowth Strategy Posts Its June 2025 Performance
Hedge Fund Golden Eagle Hypergrowth Strategy #Investment Update
Cooper Creek Partners LLC (Class A) Posts Its June 2025 Results
Hedge Fund Cooper Creek Partners LLC (Class A) #Investment Update
SDI Basic Partner Fund - AlphaMaven Performance Report
Hedge Fund Basic Partner Fund #Investment Update
SDI Partners - Accredited Partner Fund - AlphaMaven Performance Report
Hedge Fund SDI Partners - Accredited Partner Fund #Investment Update
Seven UCITS - Seven Force 5 - I Share AlphaMaven Performance Report
Hedge Fund Seven UCITS - Seven Force 5 - I Share #Investment Update
Seven European Equity Fund (EUR) - AlphaMaven Performance Report
Hedge Fund Seven UCITS - Seven European Equity Fund (EUR) #Investment Update
Seven UCITS - Seven Force 2 (I Shares) - AlphaMaven Performance Report
Hedge Fund Seven UCITS - Seven Force 2 - I Shares #Investment Update
Seven Absolute Return Program - AlphaMaven Performance Report
Hedge Fund Seven Absolute Return Program #Investment Update
AlphaMaven Managed Futures Index
Managed Futures AlphaMaven Managed Futures Index #Investment Update
AlphaMaven Real Estate Index
Real Estate AlphaMaven Real Estate Index #Investment Update
CREATE A FREE MEMBERSHIP
View Member Posts Listings
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Exome Asset Management's Worldwide Healthcare Partners Fund Posts Its May 2025 Results
- posted by: Worldwide Healthcare Partners
Andrea Alms Video:  Money In Motion 159 - Bitcoin Energy Mining
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 163 -Revenue Models Of The AI Drug Development Process Part 2
- posted by: BrookDell Partners
Exome Asset Management's Emerging Markets Healthcare Partners Fund Posts Its May 2025 Results
- posted by: Emerging Markets Healthcare Partners Strategy
Andrea Alms Video:  Money In Motion 161 - AI Drug Development Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 162 - Revenue Models Of The AI Drug Development Process Part 1
- posted by: BrookDell Partners
DLD Master Fund Investor Presentation - May 2025
- posted by: DLD Master Fund
Andrea Alms Video:  Money In Motion 160 - Pharma Q1 2025 Revenue Decline
- posted by: BrookDell Partners
DLD Master Fund Posts Its May 2025 Performance
- posted by: DLD Master Fund
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

Subscribe to our FREE DAILY newsletter

Please Select Industry Primary Role*
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.